{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "authorship_tag": "ABX9TyMmuut0Vvjw4h5VU0p/dbfF",
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/wangzuohao/ipynb/blob/main/LillyEarning.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Lilly Earnings Call Transcript\n",
        "\n",
        "Let's tie this back to finance. I have attached some text from a recent [Microsoft earnings call here](https://gist.github.com/hackingthemarkets/1c827a7750384fcf52c84594ef216a2d). Click on \"raw\" and save the file as a CSV. Upload it to Google Colab as microsoft-earnings.csv. Let's use what we just learned to perform a semantic search on sentences in the Microsoft earnings call. We'll start by reading the paragraphs into a pandas dataframe."
      ],
      "metadata": {
        "id": "K1y7jHQB09XB"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install openai -q\n"
      ],
      "metadata": {
        "id": "5MucJqil1Jrx"
      },
      "execution_count": 6,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "import openai\n",
        "import pandas as pd\n",
        "import numpy as np\n",
        "from getpass import getpass\n",
        "from openai.embeddings_utils import get_embedding\n",
        "from openai.embeddings_utils import cosine_similarity\n",
        "\n",
        "openai.api_key = \"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\""
      ],
      "metadata": {
        "id": "FQLbOGwZ3ZZE"
      },
      "execution_count": 11,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "earnings_df = pd.read_csv('Lilly-earnings-cn.csv',encoding='utf-8')\n",
        "earnings_df"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 457
        },
        "id": "5Nh94uA607bT",
        "outputId": "865bc02a-219b-4f45-dd80-1228d9ad52bb"
      },
      "execution_count": 23,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                                 text\n",
              "0   2月2日，礼来公布了2022年财报，全年总营收285.41亿美元，同比增长1%；研发投入71...\n",
              "1   礼来目前的业务主要包括糖尿病、肿瘤、免疫、神经四大疾病领域。糖尿病业务一直是礼来具有优势且重...\n",
              "2   作为礼来当前的王牌产品，GLP-1受体激动剂度拉糖肽增速较2021年有所下滑，不过仍以15%...\n",
              "3   替尔泊肽是一款每周皮下注射一次的GIPR/GLP-1R双重激动剂，2022年5月首获FDA批...\n",
              "4   不过这款新型重磅降糖药的潜力不止于此，目前正在被开发用于治疗肥胖以及合并肥胖的射血分数保留性...\n",
              "5   在一项III期SURMOUNT-1研究中，第72周时不同剂量tirzepatide（5mg、...\n",
              "6   肿瘤领域，CDK4/6抑制剂阿贝西利因乳腺癌辅助治疗新适应症的扩展，市场表现一路高涨，以高达...\n",
              "7   礼来在2019年以80亿美元收购Loxo Oncology囊获的一款用于非小细胞肺癌与髓样甲...\n",
              "8   此外，收购获得的另一款肿瘤创新药BTK C481S抑制剂pirtobrutinib刚于今年1...\n",
              "9   Alimta（培美曲塞）、Cyramza（雷莫芦单抗）、Tyvyt（信迪利单抗）等产品虽然销...\n",
              "10  自免也是礼来重点布局的领域，不仅有斩获多项适应症的成熟产品IL-17A单抗Taltz（依奇珠...\n",
              "11  MNC企业对偏头痛领域一直较为重视，礼来亦是如此，目前已上市2款偏头痛药物，其中之一为Emg...\n",
              "12  令人遗憾的是，曾被寄予厚望的阿尔兹海默病（AD）新药donanemab在今年遭遇了挫折。今年..."
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-c393e4ed-73a3-4770-86ff-2ce0c9deaa0c\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>text</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>2月2日，礼来公布了2022年财报，全年总营收285.41亿美元，同比增长1%；研发投入71...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>礼来目前的业务主要包括糖尿病、肿瘤、免疫、神经四大疾病领域。糖尿病业务一直是礼来具有优势且重...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>作为礼来当前的王牌产品，GLP-1受体激动剂度拉糖肽增速较2021年有所下滑，不过仍以15%...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>替尔泊肽是一款每周皮下注射一次的GIPR/GLP-1R双重激动剂，2022年5月首获FDA批...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>不过这款新型重磅降糖药的潜力不止于此，目前正在被开发用于治疗肥胖以及合并肥胖的射血分数保留性...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>在一项III期SURMOUNT-1研究中，第72周时不同剂量tirzepatide（5mg、...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>6</th>\n",
              "      <td>肿瘤领域，CDK4/6抑制剂阿贝西利因乳腺癌辅助治疗新适应症的扩展，市场表现一路高涨，以高达...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7</th>\n",
              "      <td>礼来在2019年以80亿美元收购Loxo Oncology囊获的一款用于非小细胞肺癌与髓样甲...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>8</th>\n",
              "      <td>此外，收购获得的另一款肿瘤创新药BTK C481S抑制剂pirtobrutinib刚于今年1...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>9</th>\n",
              "      <td>Alimta（培美曲塞）、Cyramza（雷莫芦单抗）、Tyvyt（信迪利单抗）等产品虽然销...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>10</th>\n",
              "      <td>自免也是礼来重点布局的领域，不仅有斩获多项适应症的成熟产品IL-17A单抗Taltz（依奇珠...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>11</th>\n",
              "      <td>MNC企业对偏头痛领域一直较为重视，礼来亦是如此，目前已上市2款偏头痛药物，其中之一为Emg...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>12</th>\n",
              "      <td>令人遗憾的是，曾被寄予厚望的阿尔兹海默病（AD）新药donanemab在今年遭遇了挫折。今年...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-c393e4ed-73a3-4770-86ff-2ce0c9deaa0c')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-c393e4ed-73a3-4770-86ff-2ce0c9deaa0c button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-c393e4ed-73a3-4770-86ff-2ce0c9deaa0c');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 23
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "earnings_df['embedding'] = earnings_df['text'].apply(lambda x: get_embedding(x, engine='text-embedding-ada-002'))\n",
        "earnings_df.to_csv('earnings-embeddings.csv')"
      ],
      "metadata": {
        "id": "ys7id43Q3MQB"
      },
      "execution_count": 24,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "earnings_search = input(\"Search earnings for a sentence:\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "QmJvMTPE3lTA",
        "outputId": "18ff23b0-e15c-4e3f-8b94-855ab2451b5e"
      },
      "execution_count": 25,
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Search earnings for a sentence:肿瘤领域有什么进展\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "earnings_search_vector = get_embedding(earnings_search, engine=\"text-embedding-ada-002\")\n",
        "earnings_search_vector"
      ],
      "metadata": {
        "id": "y1ZliJHk3t4N"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "earnings_df[\"similarities\"] = earnings_df['embedding'].apply(lambda x: cosine_similarity(x, earnings_search_vector))\n",
        "earnings_df"
      ],
      "metadata": {
        "id": "I0vIdInF3xbi"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "earnings_df.sort_values(\"similarities\", ascending=False)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 457
        },
        "id": "mHvqo2Gg4Pqv",
        "outputId": "a7d7cf6a-05af-4b0f-9bd1-f9d352b414bb"
      },
      "execution_count": 28,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                                 text  \\\n",
              "6   肿瘤领域，CDK4/6抑制剂阿贝西利因乳腺癌辅助治疗新适应症的扩展，市场表现一路高涨，以高达...   \n",
              "8   此外，收购获得的另一款肿瘤创新药BTK C481S抑制剂pirtobrutinib刚于今年1...   \n",
              "7   礼来在2019年以80亿美元收购Loxo Oncology囊获的一款用于非小细胞肺癌与髓样甲...   \n",
              "10  自免也是礼来重点布局的领域，不仅有斩获多项适应症的成熟产品IL-17A单抗Taltz（依奇珠...   \n",
              "12  令人遗憾的是，曾被寄予厚望的阿尔兹海默病（AD）新药donanemab在今年遭遇了挫折。今年...   \n",
              "3   替尔泊肽是一款每周皮下注射一次的GIPR/GLP-1R双重激动剂，2022年5月首获FDA批...   \n",
              "5   在一项III期SURMOUNT-1研究中，第72周时不同剂量tirzepatide（5mg、...   \n",
              "1   礼来目前的业务主要包括糖尿病、肿瘤、免疫、神经四大疾病领域。糖尿病业务一直是礼来具有优势且重...   \n",
              "4   不过这款新型重磅降糖药的潜力不止于此，目前正在被开发用于治疗肥胖以及合并肥胖的射血分数保留性...   \n",
              "2   作为礼来当前的王牌产品，GLP-1受体激动剂度拉糖肽增速较2021年有所下滑，不过仍以15%...   \n",
              "9   Alimta（培美曲塞）、Cyramza（雷莫芦单抗）、Tyvyt（信迪利单抗）等产品虽然销...   \n",
              "11  MNC企业对偏头痛领域一直较为重视，礼来亦是如此，目前已上市2款偏头痛药物，其中之一为Emg...   \n",
              "0   2月2日，礼来公布了2022年财报，全年总营收285.41亿美元，同比增长1%；研发投入71...   \n",
              "\n",
              "                                            embedding  similarities  \n",
              "6   [-0.020099161192774773, -0.006610133685171604,...      0.833059  \n",
              "8   [-0.03800026327371597, -0.00675713736563921, 0...      0.797889  \n",
              "7   [-0.032038792967796326, -0.00921974703669548, ...      0.796360  \n",
              "10  [-0.01668691821396351, -0.007388939615339041, ...      0.791211  \n",
              "12  [-0.020152520388364792, -0.0021475665271282196...      0.789675  \n",
              "3   [-0.027490833774209023, -0.011897805146872997,...      0.781920  \n",
              "5   [-0.028329981490969658, -0.008187936618924141,...      0.779824  \n",
              "1   [-0.0019808970391750336, -0.013228886760771275...      0.778559  \n",
              "4   [-0.030129816383123398, -0.011884691193699837,...      0.775883  \n",
              "2   [-0.01716248132288456, -0.009829298593103886, ...      0.772710  \n",
              "9   [-0.02357872761785984, -0.02251194231212139, -...      0.770434  \n",
              "11  [-0.021228766068816185, 0.006897664163261652, ...      0.761705  \n",
              "0   [-0.008886326104402542, -0.02552608586847782, ...      0.753805  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-4e654d5f-2e9c-4e5d-abdd-e1bcec3f4d7c\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>text</th>\n",
              "      <th>embedding</th>\n",
              "      <th>similarities</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>6</th>\n",
              "      <td>肿瘤领域，CDK4/6抑制剂阿贝西利因乳腺癌辅助治疗新适应症的扩展，市场表现一路高涨，以高达...</td>\n",
              "      <td>[-0.020099161192774773, -0.006610133685171604,...</td>\n",
              "      <td>0.833059</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>8</th>\n",
              "      <td>此外，收购获得的另一款肿瘤创新药BTK C481S抑制剂pirtobrutinib刚于今年1...</td>\n",
              "      <td>[-0.03800026327371597, -0.00675713736563921, 0...</td>\n",
              "      <td>0.797889</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7</th>\n",
              "      <td>礼来在2019年以80亿美元收购Loxo Oncology囊获的一款用于非小细胞肺癌与髓样甲...</td>\n",
              "      <td>[-0.032038792967796326, -0.00921974703669548, ...</td>\n",
              "      <td>0.796360</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>10</th>\n",
              "      <td>自免也是礼来重点布局的领域，不仅有斩获多项适应症的成熟产品IL-17A单抗Taltz（依奇珠...</td>\n",
              "      <td>[-0.01668691821396351, -0.007388939615339041, ...</td>\n",
              "      <td>0.791211</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>12</th>\n",
              "      <td>令人遗憾的是，曾被寄予厚望的阿尔兹海默病（AD）新药donanemab在今年遭遇了挫折。今年...</td>\n",
              "      <td>[-0.020152520388364792, -0.0021475665271282196...</td>\n",
              "      <td>0.789675</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>替尔泊肽是一款每周皮下注射一次的GIPR/GLP-1R双重激动剂，2022年5月首获FDA批...</td>\n",
              "      <td>[-0.027490833774209023, -0.011897805146872997,...</td>\n",
              "      <td>0.781920</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>在一项III期SURMOUNT-1研究中，第72周时不同剂量tirzepatide（5mg、...</td>\n",
              "      <td>[-0.028329981490969658, -0.008187936618924141,...</td>\n",
              "      <td>0.779824</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>礼来目前的业务主要包括糖尿病、肿瘤、免疫、神经四大疾病领域。糖尿病业务一直是礼来具有优势且重...</td>\n",
              "      <td>[-0.0019808970391750336, -0.013228886760771275...</td>\n",
              "      <td>0.778559</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>不过这款新型重磅降糖药的潜力不止于此，目前正在被开发用于治疗肥胖以及合并肥胖的射血分数保留性...</td>\n",
              "      <td>[-0.030129816383123398, -0.011884691193699837,...</td>\n",
              "      <td>0.775883</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>作为礼来当前的王牌产品，GLP-1受体激动剂度拉糖肽增速较2021年有所下滑，不过仍以15%...</td>\n",
              "      <td>[-0.01716248132288456, -0.009829298593103886, ...</td>\n",
              "      <td>0.772710</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>9</th>\n",
              "      <td>Alimta（培美曲塞）、Cyramza（雷莫芦单抗）、Tyvyt（信迪利单抗）等产品虽然销...</td>\n",
              "      <td>[-0.02357872761785984, -0.02251194231212139, -...</td>\n",
              "      <td>0.770434</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>11</th>\n",
              "      <td>MNC企业对偏头痛领域一直较为重视，礼来亦是如此，目前已上市2款偏头痛药物，其中之一为Emg...</td>\n",
              "      <td>[-0.021228766068816185, 0.006897664163261652, ...</td>\n",
              "      <td>0.761705</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>2月2日，礼来公布了2022年财报，全年总营收285.41亿美元，同比增长1%；研发投入71...</td>\n",
              "      <td>[-0.008886326104402542, -0.02552608586847782, ...</td>\n",
              "      <td>0.753805</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-4e654d5f-2e9c-4e5d-abdd-e1bcec3f4d7c')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-4e654d5f-2e9c-4e5d-abdd-e1bcec3f4d7c button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-4e654d5f-2e9c-4e5d-abdd-e1bcec3f4d7c');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 28
        }
      ]
    }
  ]
}